title: The FDA warning against prolonged sedation with propofol in children remains warranted.
authors.forename: Kate
authors.initials: K
authors.lastname: Felmet
authors.forename: Trung
authors.initials: T
authors.lastname: Nguyen
authors.forename: Robert S
authors.initials: RS
authors.lastname: Clark
authors.forename: Dick
authors.initials: D
authors.lastname: Orr
authors.forename: Joseph
authors.initials: J
authors.lastname: Carcillo
mesh_terms: D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D016638:Critical Illness / Q000628:therapy; D005227:Fatty Acids / Q000378:metabolism; D017052:Hospital Mortality; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects; D007223:Infant; D015278:Intensive Care Units, Pediatric; D015742:Propofol / Q000008:administration & dosage / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D005227:Fatty Acids; D006993:Hypnotics and Sedatives; D015742:Propofol